These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11252887)

  • 1. Gemcitabine and Pemetrexed disodium in treating breast cancer.
    Adjei AA
    Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):34-7. PubMed ID: 11252887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumors.
    Adjei AA
    Ann Oncol; 2000 Oct; 11(10):1335-41. PubMed ID: 11106124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemetrexed in pancreatic cancer.
    Kindler HL
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):49-53. PubMed ID: 12571811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemetrexed (Alimta): a novel multitargeted antifolate agent.
    Adjei AA
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):145-56. PubMed ID: 12722874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies of pemetrexed and gemcitabine combinations.
    Adjei AA
    Ann Oncol; 2006 May; 17 Suppl 5():v29-32. PubMed ID: 16807459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors.
    Yuan Y; Cohen DJ; Love E; Yaw M; Levinson B; Nicol SJ; Hochster HS
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):371-8. PubMed ID: 20978761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine and pemetrexed disodium combinations in vitro and in vivo.
    Adjei AA
    Lung Cancer; 2001 Dec; 34 Suppl 4():S103-5. PubMed ID: 11742712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemetrexed (Alimta) and gemcitabine in breast cancer patients previously treated with anthracyclines and taxanes.
    Adjei AA
    Clin Breast Cancer; 2002 May; 3 Suppl 1():21-3. PubMed ID: 12057041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer.
    Le Chevalier T
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):37-44. PubMed ID: 12947960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief communication: use of the multitargeted antifolate pemetrexed (Alimta) in genitourinary cancer.
    Misset JL
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):36-9. PubMed ID: 11894006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pemetrexed/gemcitabine combination in pancreatic cancer.
    Kindler HL
    Cancer; 2002 Aug; 95(4 Suppl):928-32. PubMed ID: 12209673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemetrexed: an active new agent for breast cancer.
    O'Shaughnessy JA
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):57-62. PubMed ID: 12571813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
    Bunn PA
    Semin Oncol; 2002 Jun; 29(3 Suppl 9):17-22. PubMed ID: 12094334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemetrexed in the treatment of selected solid tumors.
    Adjei AA
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):50-3. PubMed ID: 12023793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical and clinical studies with combinations of pemetrexed and gemcitabine.
    Adjei AA
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):30-4. PubMed ID: 12571808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemetrexed: a promising new treatment for breast cancer.
    O'Shaughnessy JA; Gennari A; Conte P
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):36-41. PubMed ID: 12023791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Pemetrexed (Alimta , LY231514) in lung cancer therapy.
    Molina JR; Adjei AA
    Clin Lung Cancer; 2003 Jul; 5(1):21-7. PubMed ID: 14596699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALIMTA (pemetrexed disodium, LY231514, MTA): clinical experience in non-small cell lung cancer.
    Novello S; le Chevalier T
    Lung Cancer; 2001 Dec; 34 Suppl 4():S107-9. PubMed ID: 11742713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of pemetrexed combined with gemcitabine for non-small-cell lung cancer.
    Ngeow J; Toh CK
    Curr Drug Targets; 2010 Jan; 11(1):61-6. PubMed ID: 19839926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of phase I/II pemetrexed studies.
    Hanauske AR; Dittrich C; Otero J
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):18-25. PubMed ID: 15655932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.